Update on international supplement regulations

AHPA Alerts

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe

View recent alerts:

  • Legal Alerts News on dietary supplement laws, regulations and enforcement
  • Science Alerts The latest research on herbs and botanicals
  • Market Alerts Herbal market trends and AHPA-member press releases
  • Media Alerts Media coverage of the herbal industry 
  • Cannabis Alerts The latest research and news about hemp, CBD and medical marijuana
  • Cosmetic Alerts Regulatory updates and personal care product news

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

Update on international supplement regulations

IADSA October 2016 Newsflash

Published: Friday, October 21, 2016

Download the Oct. 2016 IADSA Newsflash >>

AHPA is an active member of IADSA and distributes the IADSA Newsflash as a member benefit. IADSA is an association focused on the globalization of food supplement markets and regulatory challenges. This issue of the IADSA Newsflash includes:

  • Thailand drafts notification on a negative list for botanicals or parts of botanicals for use in foods, including food supplements. The new regulation is expected to be implemented in 2017.
  • Australia is announcing new requirements for the labeling of non-prescription medicines, which will also apply to food supplements. The new requirements will be implemented over four years.
  • New Zealand has extended the deadline for submission of substances to the Natural Health Products Bill until October 31, 2016.
  • Following concerns raised by several countries, the European Commission (EC) has requested the European Food Safety Authority (EFSA) to provide a scientific opinion on the safety of green tea catechins with a proposed deadline of October 2017.
  • The EC has recently initiated the Article 8 procedure for the intake of hydroxyanthracene derivatives in order to address the safety concerns raised during the authorization of a health claim on the improvement of bowel function for which a positive opinion was delivered by EFSA and has requested that EFSA conduct a risk assessment. The opinion is expected in June 2017.
  • The EC has launched a consultation to consider potential improvements to the Mutual Recognition Regulation, which is intended to provide for free movement of goods within the EU where legislation has not been harmonized.
  • The Dutch Journal of Medicine released an article warning about the safe use of red yeast rice supplements.
  • ANVISA in Brazil indicates the intention to continue development of regulation specific to the category of food supplements.
  • Health Canada is conducting a consultation on potential regulatory changes for self-care products, including natural health products, OTCs, and cosmetics.
Print

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.